Chronic Liver Disease without Cirrhosis (Autoimmune Hepatitis / NASH / Primary Sclerosing Cholangitis) C&P Exam Prep

Liver Function Tests (LFTs): ALT, AST, Alkaline Phosphatase, Bilirubin

What it measures: Hepatocellular inflammation, cholestatic injury, and liver synthetic function. Elevated ALT/AST indicate ongoing hepatocyte damage; elevated alkaline phosphatase and bilirubin can indicate bile duct involvement (particularly relevant for PSC and Autoimmune Hepatitis).

What to expect: The examiner will record the most recent values from your lab work. You should bring printed copies of your most recent labs (within the past 6-12 months) and any prior labs showing trends of elevation or normalization. The examiner will note results in DBQ fields for ALT, AST, alkaline phosphatase, and bilirubin.

Pain considerations: Liver disease itself does not typically cause pain from LFT testing; however, the lab values directly support the severity tier of your rating. Abnormal trends over time are more persuasive than a single result.

INR/PT (Prothrombin Time)

What it measures: Coagulation status and liver synthetic capacity. An elevated INR indicates the liver is not producing adequate clotting factors, a sign of significant liver dysfunction.

What to expect: The examiner records your most recent INR/PT. Coagulopathy is listed as a separate complication checkbox on the DBQ, so an elevated INR can support documentation of this additional finding.

Pain considerations: Coagulopathy from liver disease increases bleeding risk and can cause easy bruising, prolonged bleeding from minor wounds, and fear of injury - all of which impact daily function and quality of life. Describe these functional impacts clearly.

Creatinine

What it measures: Kidney function. In the context of chronic liver disease, elevated creatinine may indicate hepatorenal syndrome, a serious complication that should be documented on the DBQ.

What to expect: The examiner will record your creatinine level. If elevated, this may trigger documentation of hepatorenal syndrome as a complication.

Pain considerations: Hepatorenal syndrome represents multi-organ involvement. Describe any urinary changes, fluid retention, or edema you experience, as these support the overall functional picture.

MELD Score (Model for End-Stage Liver Disease)

What it measures: A composite score based on bilirubin, INR, and creatinine that quantifies liver disease severity and is used to prioritize transplant candidates. The DBQ has a dedicated field for the MELD score.

What to expect: The examiner may record your MELD score if known. Ask your treating hepatologist what your current MELD score is before the exam.

Pain considerations: A higher MELD score objectively demonstrates disease severity independent of subjective symptom reporting. This score is critical for higher-tier ratings.

Imaging Studies (Ultrasound, CT, MRI/MRCP)

What it measures: Structural liver changes, biliary tract abnormalities (especially for PSC), presence of hepatomegaly, splenomegaly, ascites, portal hypertension findings, and liver texture changes (fibrosis, steatosis for NASH).

What to expect: The examiner will record results of any recent imaging. For PSC, MRCP is the primary imaging modality showing biliary stricturing. For NASH, imaging may show hepatic steatosis. For Autoimmune Hepatitis, imaging may show hepatomegaly or early fibrosis changes.

Pain considerations: Imaging findings are objective evidence that corroborates your subjective symptoms. Hepatomegaly on imaging directly supports the symptom of abdominal discomfort and fullness you may describe.

Liver Biopsy (if applicable)

What it measures: Degree of hepatic inflammation, fibrosis staging (F0-F4), and histological features diagnostic of Autoimmune Hepatitis, NASH, or PSC. Confirms diagnosis and disease activity.

What to expect: The examiner will record biopsy results if available. Fibrosis stage and histological activity index are particularly relevant to documenting disease progression.

Pain considerations: Biopsy findings provide an objective baseline. If your biopsy showed significant fibrosis, this directly supports the progressive nature of your disease even on days when your labs appear relatively stable.

100%

Progressive chronic liver disease requiring use of BOTH parenteral antiviral therapy (direct antiviral agents) AND parenteral immunomodulatory therapy (interferon and other); and for six months following discontinuance of such treatment.

From 38 CFR: Under 38 CFR - 4.114, DC 7345, a 100% rating requires documented use of both parenteral antiviral AND parenteral immunomodulatory therapy simultaneously. This rating also applies for six months after discontinuing such treatment. The veteran must be receiving or have recently completed these specific categories of parenteral (injected/infused) therapies - oral medications alone do not qualify for this tier.

60%

Progressive chronic liver disease requiring continuous medication AND causing SUBSTANTIAL weight loss AND at least TWO of the following six symptoms: (1) daily fatigue, (2) malaise, (3) anorexia, (4) hepatomegaly, (5) pruritus, (6) arthralgia.

From 38 CFR: Under 38 CFR - 4.114, DC 7345, a 60% rating requires the combination of continuous medication PLUS substantial weight loss PLUS at least two qualifying symptoms. 'Substantial weight loss' is not defined in the regulation numerically but should be documented with a clear baseline and current weight, and the treating physician should attribute the loss to the liver disease. For PSC, pruritus is often a dominant symptom. For Autoimmune Hepatitis, arthralgia and fatigue are common. Ensure your treating provider documents the medication as 'continuous' and links the weight loss to your liver disease.

40%

Progressive chronic liver disease requiring continuous medication AND causing MINOR weight loss AND at least TWO of the following six symptoms: (1) daily fatigue, (2) malaise, (3) anorexia, (4) hepatomegaly, (5) pruritus, (6) arthralgia.

From 38 CFR: Under 38 CFR - 4.114, DC 7345, the 40% tier mirrors the 60% criteria but with minor (rather than substantial) weight loss. If you have lost some weight related to your liver disease - even 5-10 pounds due to anorexia or dietary restrictions - this should be documented with a baseline weight and current weight. Ensure your treating physician attributes the weight loss to the liver disease, not other causes.

20%

Chronic liver disease with at least ONE of the following: (1) intermittent fatigue, (2) malaise, (3) anorexia, (4) hepatomegaly, or (5) pruritus.

From 38 CFR: Under 38 CFR - 4.114, DC 7345, a 20% rating requires only ONE of the five listed symptoms. Note that 'arthralgia' is NOT listed at the 20% tier - it is only a qualifying symptom at the 40/60/100% tiers. Also note that at this tier, 'fatigue' must be 'intermittent' rather than 'daily.' If your fatigue is daily and debilitating, you may qualify for a higher tier. Even if your disease appears controlled on medication, if you still have hepatomegaly on imaging, that alone satisfies the 20% criterion.

0%

Asymptomatic: Chronic liver disease that is asymptomatic, or with only a history of liver disease without current qualifying symptoms.

From 38 CFR: Under 38 CFR - 4.114, DC 7345, a 0% (noncompensable) rating is assigned when the condition is asymptomatic. However, a 0% rating still establishes service connection, which is important for future claims if the condition worsens. Even at 0%, having service connection established protects your ability to seek higher ratings as the disease progresses. If you are asymptomatic, still document any ongoing monitoring, follow-up appointments, medication for prevention, and any laboratory abnormalities.

Daily Fatigue

How to describe it: Describe how fatigue affects your ability to complete daily tasks, maintain employment, and engage in activities you previously enjoyed. Specify the frequency (daily vs. intermittent), severity (mild, moderate, severe), duration of fatigue episodes, and whether rest alleviates it. Distinguish between 'tired' and 'debilitated' - explain if you must rest mid-day, if you cannot complete a full workday, or if fatigue prevents you from leaving the house on bad days.

Example: On my worst days, I wake up already exhausted even after 8-9 hours of sleep. By mid-morning I need to lie down. I cannot drive, cook, or care for myself without significant effort. I have missed work multiple times per month because I simply cannot function. The fatigue is different from normal tiredness - it feels like my body is shutting down, and nothing relieves it except resting for hours.

Examiner listens for: Whether fatigue is daily (qualifying for 40%+ tiers) vs. intermittent (qualifying for 20% tier). Functional impact on work, self-care, and daily activities. Whether fatigue is attributable to the liver disease vs. other conditions. How fatigue has changed over time as the disease has progressed.

Avoid: Saying 'I get tired sometimes' when your fatigue is actually daily and debilitating. Failing to connect your fatigue specifically to your liver disease. Describing your best days rather than your typical or worst days. Saying 'I manage' without explaining what managing costs you functionally.

Malaise

How to describe it: Malaise is a generalized sense of feeling unwell, uncomfortable, or lacking energy that goes beyond simple tiredness. Describe it as a pervasive sense of illness, physical discomfort throughout your body, lack of motivation or energy that is not tied to a specific cause. Explain how it differs from fatigue - it is a constant background feeling of being sick, not just tired.

Example: On bad days I feel like I have the flu even though I don't have a fever or infection. Everything feels heavy and wrong. I can't focus, I don't want to eat, I feel vaguely nauseated, and I just feel systemically unwell from the moment I wake up until I go to sleep. This happens several days per week and is directly tied to my liver condition flaring.

Examiner listens for: Duration and frequency of malaise episodes. Whether malaise is constant or episodic. Functional impact - does it prevent work, social engagement, self-care? Is it clearly attributable to the liver disease (not depression or other conditions, though these may co-exist)?

Avoid: Describing malaise as 'just not feeling great' without elaborating on its functional impact. Conflating malaise with depression without separately describing the physical component. Not mentioning malaise at all because it seems vague - it is a named criterion in the rating schedule.

Anorexia (Loss of Appetite)

How to describe it: Anorexia in the medical context means loss of appetite - not the eating disorder. Describe whether you feel hungry normally, whether food has lost its appeal, whether you feel full very quickly (early satiety), whether nausea accompanies eating, and how this has affected your weight, nutritional status, and daily eating habits. Quantify: 'I used to eat three full meals per day; now I eat one small meal and maybe a snack because I have no appetite and food makes me feel nauseated.'

Example: During my worst periods, I go the entire day eating almost nothing - maybe a few crackers and some water - because the thought of food makes me feel sick. Even when I force myself to eat, I can only manage a few bites before feeling full and nauseated. I have lost weight because of this and my doctor is concerned about my nutritional status.

Examiner listens for: Whether anorexia is chronic vs. intermittent. Impact on weight (ties directly to the weight loss criterion at 40%/60% tiers). Whether dietary restrictions have been recommended by your provider (e.g., low-sodium diet for liver disease). Whether nutritional supplementation or enteral nutrition has been required.

Avoid: Saying 'my appetite is okay' if you actually eat significantly less than you used to. Not connecting poor appetite to your confirmed weight loss. Failing to mention dietary modifications your doctor has required due to your liver condition.

Hepatomegaly (Enlarged Liver)

How to describe it: Hepatomegaly is typically detected on physical exam or imaging rather than self-reported symptoms. However, you may describe associated symptoms: right upper quadrant fullness or heaviness, a sensation of pressure under your right rib cage, discomfort after meals, or a feeling of abdominal fullness. Reference your imaging reports or physical exam findings that confirmed hepatomegaly.

Example: I have a persistent heaviness and pressure under my right ribs that gets worse after eating or when I am active. My ultrasound from [date] confirmed my liver is enlarged. The discomfort limits how much I can eat at one time and makes it uncomfortable to bend forward or lift anything.

Examiner listens for: Confirmation of hepatomegaly on physical exam (palpable liver below costal margin) or recent imaging. Associated symptoms: right upper quadrant discomfort, early satiety, abdominal fullness. This is an objective finding - ensure it is documented in your recent labs and imaging.

Avoid: Not mentioning abdominal discomfort or fullness that could indicate hepatomegaly. Assuming the examiner already knows about imaging findings without bringing documentation. Failing to note that your treating physician has documented hepatomegaly on physical exam at clinic visits.

Pruritus (Chronic Itching)

How to describe it: Pruritus in liver disease - especially PSC and cholestatic conditions - can be severe and debilitating. Describe the location (generalized vs. specific areas), severity (mild vs. sleep-disrupting), time of day (worse at night), what helps and what does not, impact on sleep and daily functioning, and any skin changes from scratching (excoriations, skin thickening). For PSC, cholestatic pruritus can be one of the most functionally limiting symptoms.

Example: On my worst nights, the itching is so severe that I cannot sleep. I scratch until I bleed in some areas. I have tried multiple antihistamines and topical creams with limited relief. The itching is not from dry skin - my hepatologist confirmed it is related to bile salt deposition from my PSC. I wake up multiple times per night, I am sleep-deprived, and this affects my functioning every day.

Examiner listens for: Whether pruritus is confirmed as hepatic/cholestatic in origin (not dermatological). Frequency and severity. Impact on sleep, concentration, and daily activities. Treatments attempted and their effectiveness. This is particularly important for PSC where pruritus can be the dominant disabling symptom.

Avoid: Dismissing itching as minor when it actually disrupts sleep and daily activities. Not connecting pruritus to your liver condition specifically. Failing to mention secondary effects: sleep deprivation, skin damage from scratching, psychological impact of chronic itch.

Arthralgia (Joint Pain)

How to describe it: Arthralgia - joint pain without documented joint swelling or inflammation - is a recognized extrahepatic manifestation of Autoimmune Hepatitis and other liver conditions. Describe which joints are affected, frequency of pain, severity (1-10 scale), functional limitations (difficulty gripping, walking, climbing stairs, performing self-care), and whether the joint pain fluctuates with liver disease activity. Note: arthralgia is a qualifying symptom ONLY at the 40%, 60%, and 100% rating tiers - not at the 20% tier.

Example: During liver disease flares, my knees, wrists, and shoulders ache significantly - I would rate the pain 6-7 out of 10. On those days I cannot open jars, type at a keyboard for more than a few minutes, or walk more than a block without significant discomfort. The joint pain resolves partially when my liver function improves, which confirms to me it is tied to my autoimmune hepatitis activity.

Examiner listens for: Whether joint pain is clearly attributable to the liver disease (extrahepatic manifestation) vs. an independent orthopedic condition. Which joints are affected. Frequency and functional impact. Relationship between arthralgia and liver disease activity flares.

Avoid: Not mentioning joint pain at all if you experience it, especially with Autoimmune Hepatitis. Attributing joint pain only to arthritis without noting its relationship to liver disease flares. Understating the functional impact of joint pain on daily activities and work capacity.

Weight Loss

How to describe it: Weight loss is a specific rating criterion at the 40% and 60% tiers. You must document a baseline weight (your pre-disease or pre-symptom weight) and your current weight. 'Minor' vs. 'substantial' weight loss is not numerically defined in the regulations, but generally 10-15% of body weight or more may be considered substantial. The weight loss must be attributed to the liver disease - specifically anorexia, malabsorption, or other disease-related causes - not to intentional dieting or other conditions.

Example: Before my liver disease worsened, I weighed [X] pounds. Over the past [time period], I have lost [Y] pounds without intentionally dieting. My appetite has been severely diminished, I become nauseated after eating, and my hepatologist has documented in my records that the weight loss is related to my liver disease. I am now [Z] pounds and my physician is monitoring my nutritional status.

Examiner listens for: Specific baseline and current weight with dates. Physician attribution of weight loss to the liver disease. Whether weight loss is ongoing or has stabilized. Nutritional interventions attempted (dietary consults, supplements, etc.). The weight loss criterion is binary at each tier - ensure both the weight documentation and the physician attribution are in your records.

Avoid: Not knowing your baseline weight before disease onset. Failing to have your physician document in writing that weight loss is attributed to your liver condition. Attributing weight loss to other factors (stress, aging) without connecting it to the liver disease. Not bringing written documentation of weight trends over time.

Treatment Requirements (Continuous Medication, Parenteral Therapy)

How to describe it: The type of treatment you require is a defining factor in your rating tier. Clearly communicate whether your treatment is: (1) oral continuous medication (qualifies for 40-60% tiers), or (2) parenteral antiviral therapy AND parenteral immunomodulatory therapy simultaneously (qualifies for 100% tier or six-month post-treatment period). Provide exact medication names, routes of administration, doses, start dates, and whether treatment is expected to be ongoing.

Example: I have been taking [medication name] continuously since [date] without any planned discontinuation date. My hepatologist has documented this as a lifetime requirement for my autoimmune hepatitis to prevent acute liver failure. Despite this medication, I still experience significant symptoms including [list symptoms], which demonstrates that my disease is not fully controlled by medication alone.

Examiner listens for: Whether medication is 'continuous' (ongoing indefinitely) vs. a completed treatment course. Whether medications are parenteral (injected/infused) or oral. Whether you are within six months of completing parenteral combination therapy. The specific medication names and whether they constitute antiviral vs. immunomodulatory therapy. Whether treatment is for the liver condition itself vs. a separate condition.

Avoid: Not being able to name your medications and their routes of administration. Failing to clarify that your medication is prescribed as a continuous, indefinite treatment. Confusing oral immunosuppressants (prednisone, azathioprine) with parenteral immunomodulatory therapy - these are different categories for rating purposes. Not mentioning medications at all because you think the examiner already knows.

Functional Impact on Daily Life and Work

How to describe it: Beyond listing symptoms, describe specifically how your liver disease limits your ability to work, perform self-care, maintain social relationships, and complete daily tasks. Use concrete examples: 'I can only work 4 hours before needing to rest.' 'I have been unable to maintain full-time employment since [date].' 'I need help with cooking and cleaning on bad days.' 'I have had to decline social invitations due to fatigue and pruritus.' The DBQ has a dedicated field for functional impact.

Example: On my worst days - which occur approximately [X times per week/month] - I cannot work, cannot drive safely due to fatigue and cognitive fog, cannot prepare meals, and require assistance with basic personal care. Even on my better days, I can only sustain activity for [X hours] before needing to rest for [X hours]. This has resulted in [specific impacts: job loss, reduced hours, inability to maintain household, strained relationships].

Examiner listens for: Specific functional limitations tied to each symptom. Impact on employability. Activities that have been eliminated or significantly reduced. Whether the veteran requires assistance from others. Consistency between reported functional limitations and documented disease severity.

Avoid: Saying 'I get by' or 'I manage' without explaining the cost of that management. Describing only your best days rather than your typical and worst days. Not mentioning employment impacts, even if you are still employed but working reduced hours or with accommodations. Failing to describe the cumulative daily burden of managing multiple symptoms simultaneously.